Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05018611 · ClinicalTrials.gov registry record · NA
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
A NA study of HIV Prevention, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 5,100
- Enrollment target
- 1
- Study location
NCT05018611: Recruiting NA study of HIV Prevention, sponsored by University of California, Los Angeles.
NCT05018611 is a NA study of HIV Prevention that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 5,100 participants, above the 222-participant average among 32 other HIV Prevention trials with a reported enrollment target (2197% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05018611, a NA study of HIV Prevention, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,100 participants
- Enrollment target
- 1
- Study location
Study Summary
The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.
Primary Outcome
Participants will be mailed and take an OraQuick In-Home HIV Test. Reactive HIV screening tests will be confirmed via dried blood spot (DBS; detectable antibodies). The main analysis will assess whether there are differences in survival (or cumulative incidence of HIV) among those randomized to LifeSkills Mobile versus those randomized to SOC.
Conditions Studied
Interventions
- BEHAVIORAL LifeSkills Mobile
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,100 participants |
| Start Date | 2022-01-22 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT05018611 shows while recruiting
NCT05018611 is an interventional study that assigns participants to a tested intervention. Its 5,100 participants enrollment target places it among the larger protocols in the corpus, above the 222-participant average among 32 other HIV Prevention trials with a reported enrollment target (2197% higher).
The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which LifeSkills Mobile is the first listed.
NCT05018611 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05018611 about?
NCT05018611 is a clinical study titled "Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW". The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.
What is the current status of trial NCT05018611?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,100 participants. The study started on 2022-01-22. Estimated completion is 2026-02-28.
What conditions does trial NCT05018611 study?
This clinical trial studies the following conditions: HIV Prevention.
What interventions are being tested in trial NCT05018611?
The interventions under investigation include: LifeSkills Mobile (BEHAVIORAL).
Who is sponsoring clinical trial NCT05018611?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05018611 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05018611's enrollment target sits among peer trials
5,100 1st of 32 higher than 32 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05701358 · 5,100 participants · NA
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- NCT06535867 · 5,122 participants
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
- NCT06292078 · 5,076 participants · NA
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
- NCT07037459 · 5,056 participants · Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI